NDEV: .... easy to do, then they can expect savings of close to $750 to $1,000 per year discounts of 30% to 40% before taxes. However, in the U.S. our patient members are averaging $300 per month and our research indicates that Canadians will be averaging anywhere from $400-$425 per month, so the intrinsic value for the where the demand chain is set at, the patient/member. Additionally, we have strategies to convert recreational users to becoming med users simply by the savings we can offer through various insurance programs.
Our model is meant to be a stand-alone plan but as of late we are negotiating with other insurance companies, clinics and cannabis verticals that want to have our plan as a value added for their patient/members and an additional revenue stream.
Keep in mind we are working with Canadian authorities diligently to push the boundaries of our coverage but right now it’s a laborious effort since no regulatory body has ever been approached by this type of business model.
We get comments from critics stating “Canada has a universal health coverage, how can our business model compete”? My argument is this, “Is there any health plan out there that completely covers all the patient’s needs healthy body or not? And the answer is no, there in lays the Novus Cannabis MedPlan.
CCIM: Let’s turn to the “investor” for a moment, does NDEV plan to obtain a listing on one of the Canadian Stock Exchanges?
NDEV: Not right now, i want the focus to be on developing Canadian market and expanding our reach to the potential 12 million Canadians that qualify for legal medical cannabis.
CCIM: Frank, this is very exciting indeed. Can employers and other groups interested in providing such a plan contact you to see how the NDEV offering can be integrated into their own benefits programs?
280
Q& A
Louis Kyron: CCIM Frank Labrozzi, CEO: NDEV